United States · FDA National Drug Code directory
Simponi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57894-071_02ee9cf4-c6d6-4239-854e-7c5976977456
- Product NDC
- 57894-071
- Form
- INJECTION, SOLUTION
- Composition / generic term
- golimumab
- Labeler
- Janssen Biotech, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20130515
- Source listing expiry
- 20271231
Source-listed ingredients
- GOLIMUMAB — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (57894-071-01) / 1 mL in 1 SYRINGE, GLASS · 57894-071-01
- 1 SYRINGE in 1 CARTON (57894-071-02) / 1 mL in 1 SYRINGE · 57894-071-02
- 1 SYRINGE in 1 CARTON (57894-071-89) / 1 mL in 1 SYRINGE · 57894-071-89
- 1 SYRINGE, GLASS in 1 CARTON (57894-071-90) / 1 mL in 1 SYRINGE, GLASS · 57894-071-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →